Cancer Family
B-Cell Malignant Neoplasm
CI-CAN-00000070Explore in graph →
Hematologic2,083 active trials46 approved drugs301 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000070Explore in graph →
Clinical trials
7,466 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,167)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04914143 | the Effect of Broken Ganoderma Lucidum Spore Powder on Quality of Life and Immune Function in Patients With Diffuse Large B-cell Lymphoma After Chemotherapy | unknown | N/A | 120 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT02037256 | Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma | completed | N/A | 23 | Barbara Ann Karmanos Cancer InstituteOTHER |
| 1 |
| May 10, 2021 |
| clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT00907452 | Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone | completed | N/A | 143 | Intergroupe Francophone du MyelomeNETWORK | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04824950 | Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)(CAMIL) | recruiting | N/A | 87 | Centre Henri BecquerelOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04792593 | Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | unknown | N/A | 15 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Mar 11, 2021 | clinicaltrials |
| NCT00943800 | Combined Haploidentical-Cord Blood Transplantation for Adults and Children | completed | N/A | 87 | University of ChicagoOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | terminated | N/A | 330 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT00525057 | Dalteparin in Preventing DVT in Participants With Cancer | completed | N/A | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT02439112 | Exercise in Patients With Multiple Myeloma(EMMY) | completed | N/A | 102 | Zealand University HospitalOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04160442 | Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL | completed | N/A | 46 | Carevive Systems, Inc.INDUSTRY | 1 | Dec 11, 2020 | clinicaltrials |
| NCT01171430 | "WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival(EVALICEMM) | completed | N/A | 104 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT04503538 | Telemedicine for Early Detection of Cytokine Release Syndrome and Neurotoxicity | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Oct 23, 2020 | clinicaltrials |
| NCT03380039 | Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma | unknown | N/A | 6 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT03302403 | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | unknown | N/A | 18 | Kang YUOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04447573 | Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 29, 2020 | clinicaltrials |
| NCT04546893 | Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04546906 | Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04496011 | Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation | unknown | N/A | 30 | Federal University of Health Science of Porto AlegreOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT03145870 | Prevalence of Asymptomatic Thrombosis in Multiple Myeloma | withdrawn | N/A | 0 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jul 17, 2020 | clinicaltrials |
| NCT04432402 | Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma | unknown | N/A | 124 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT01186978 | Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma(DLBCL) | completed | N/A | 63 | Duke UniversityOTHER | 1 | Jun 2, 2020 | clinicaltrials |
| NCT04376957 | Pilot Study of an Oral Chemotherapy Teaching Tool to Improve Adherence in Patients With Multiple Myeloma | unknown | N/A | 60 | Hamilton Health Sciences CorporationOTHER | 0 | May 6, 2020 | clinicaltrials |
| NCT02356549 | African American Cancer Clinical Trial Decisions: Testing Tailored Messages | completed | N/A | 90 | Virginia Commonwealth UniversityOTHER | 1 | Apr 1, 2020 | clinicaltrials |
| NCT01809717 | Multiple Myeloma and Exercise | completed | N/A | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT04303091 | The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients | completed | N/A | 19 | Dr. Nicole Culos-ReedOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT00656305 | ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain | completed | N/A | 147 | InSightecINDUSTRY | 5 | Feb 5, 2020 | clinicaltrials |
| NCT00014235 | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies | completed | N/A | 160 | Fred Hutchinson Cancer CenterOTHER | 3 | Jan 21, 2020 | clinicaltrials |
| NCT04215367 | Dietary Intervention With High Phenolic EVOO in CLL | completed | N/A | 21 | University of PeloponneseOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT04212858 | Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma | unknown | N/A | 100 | Assiut UniversityOTHER | 0 | Dec 30, 2019 | clinicaltrials |
| NCT00003196 | Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma | completed | N/A | 63 | Fred Hutchinson Cancer CenterOTHER | 3 | Dec 27, 2019 | clinicaltrials |
| NCT02145039 | Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases | terminated | N/A | 2 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 26, 2019 | clinicaltrials |
| NCT02435550 | iCare for Cancer Patients | terminated | N/A | 136 | University of FloridaOTHER | 1 | Dec 20, 2019 | clinicaltrials |
| NCT00001623 | Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia | completed | N/A | 41 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT03487432 | A ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions(ISAR-CALC) | completed | N/A | 74 | Deutsches Herzzentrum MuenchenOTHER | 2 | Nov 22, 2019 | clinicaltrials |
| NCT01772719 | Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid | terminated | N/A | 7 | University of LouisvilleOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT02652715 | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma | completed | N/A | 29 | Mayo ClinicOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT02719821 | Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation | completed | N/A | 17 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT02955043 | Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery | completed | N/A | 39 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT00856388 | Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders | completed | N/A | 62 | Roswell Park Cancer InstituteOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT01541644 | 1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma | completed | N/A | 27 | University of Maryland, BaltimoreOTHER | 1 | Nov 7, 2019 | clinicaltrials |
| NCT03046329 | Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans | completed | N/A | 90 | Carevive Systems, Inc.INDUSTRY | 0 | Nov 7, 2019 | clinicaltrials |
| NCT04154228 | Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI | unknown | N/A | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 6, 2019 | clinicaltrials |
| NCT00005799 | Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer | completed | N/A | 55 | Fred Hutchinson Cancer CenterOTHER | 2 | Sep 10, 2019 | clinicaltrials |
| NCT02898064 | Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace(MAPP) | completed | N/A | 2 | University Hospitals of North Midlands NHS TrustOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT04008888 | a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients | unknown | N/A | 50 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT01408043 | Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma | terminated | N/A | 25 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 14, 2019 | clinicaltrials |
| NCT01927718 | Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT) | terminated | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 29, 2019 | clinicaltrials |
| NCT02274519 | Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma | completed | N/A | 29 | Mayo ClinicOTHER | 1 | Apr 19, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Jun 4, 2021source: clinicaltrials